Presently, Stephan Toutain occupies the position of Chief Operating Officer of Anavex Life Sciences Corp.

Mr. Toutain previously occupied the position of Head-Global Commercial Development at Sarepta Therapeutics, Inc., General Manager for Alexion Pharmaceuticals, Inc. and Chief Commercial Officer of Interleukin Genetics, Inc.

Mr. Toutain received an MBA from The University of North Carolina at Charlotte and a graduate degree from Nancy-Université.